Ginger
Bradley Ginger, Arlington Heights, IL US
Patent application number | Description | Published |
---|---|---|
20100139115 | VALVELESS REGENERATIVE THERMAL OXIDIZER FOR TREATING CLOSED LOOP DRYER - A system for reducing organic contaminates from the condensate discharge of a closed loop industrial drying process. The system includes a dryer, a regenerative thermal oxidizer (RTO) in flow communication with the dryer, and an energy recovery unit in flow communication with the RTO. | 06-10-2010 |
David Ginger, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20120079630 | SUB-MICROSECOND-RESOLUTION PROBE MICROSCOPY - Methods and apparatus are provided herein for time-resolved analysis of the effect of a perturbation (e.g., a light or voltage pulse) on a sample. By operating in the time domain, the provided method enables sub-microsecond time-resolved measurement of transient, or time-varying, forces acting on a cantilever. | 03-29-2012 |
20130143331 | COMPOSITIONS AND METHODS FOR PHOTOCONTROLLED HYBRIDIZATION AND DEHYBRIDIZATION OF A NUCLEIC ACID - Compositions and methods are provided that enable light-controlled hybridization between two nucleic acid sequences. | 06-06-2013 |
David S. Ginger, Evanston, IL US
Patent application number | Description | Published |
---|---|---|
20080269073 | DIRECT WRITE NANOLITHOGRAPHIC DEPOSITION OF NUCLEIC ACIDS FROM NANOSCOPIC TIPS - The use of direct-write nanolithography to generate anchored, nanoscale patterns of nucleic acid on different substrates is described, including electrically conductive and insulating substrates. Modification of nucleic acid, including oligonucleotides, with reactive groups such as thiol groups provides for patterning with use of appropriate scanning probe microscopic tips under appropriate conditions. The reactive groups provide for chemisorption or covalent bonding to the substrate surface. The resulting nucleic acid features, which exhibit good stability, can be hybridized with complementary nucleic acids and probed accordingly with use of, for example, nanoparticles functionalized with nucleic acids. Patterning can be controlled by selection of tip treatment, relative humidity, and nucleic acid structure. | 10-30-2008 |
Douglas S. Ginger, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20100324202 | HETEROGENEOUS ETHYLENE ALPHA-OLEFIN INTERPOLYMERS - An interpolymer of ethylene and at least one alpha-olefin is claimed, wherein the ethylene interpolymer is characterized as having an average M | 12-23-2010 |
20120041148 | HETEROGENEOUS ETHYLENE/ALPHA-OLEFIN INTERPOLYMER - An interpolymer of ethylene and at least one alpha-olefin is claimed, wherein the ethylene interpolymer is characterized as having an average Mv and a valley temperature between the interpolymer and high crystalline fraction, Thc, such that the average Mv for a fraction above Thc from ATREF divided by average Mv of the whole polymer from ATREF (Mhc/Mp) is less then about 1.95 and wherein the interpolymer has a CDBI of less than 60%. The interpolymer of ethylene and at least one alpha-olefin can also be characterized as having a high density (HD) fraction and an overall density such that % HD fraction<−2733.3+2988.7x+144111.5 (x−0.92325)2 where x is the density in grams/cubic centimeter. Fabricated articles comprising the novel interpolymers are also disclosed. | 02-16-2012 |
20150148490 | POLYOLEFIN COMPOSITION - The instant invention provides a polyolefin composition suitable for packaging applications, films, multilayer structures and packaging devices made therefrom. The polyolefin composition according to the present invention comprises: an ethylene/α-olefin interpolymer composition comprising (a) from 50 to 75 percent by weight of a first ethylene/α-olefin copolymer fraction having a density in the range of 0.894 to 0.908 g/cm | 05-28-2015 |
20150148491 | POLYOLEFIN COMPOSITION - The instant invention provides a polyolefin composition suitable for injection molding applications, and method of making such injection molded articles. The polyolefin composition suitable for injection molding applications comprises: an ethylene/α-olefin interpolymer composition comprising: (a) from 25 to 50 percent by weight of a first ethylene/α-olefin copolymer fraction having a density in the range of from 0.924 to 0.937 g/cm | 05-28-2015 |
20150259586 | Sealant Composition - The instant invention provides a polyolefin composition suitable for sealant applications, sealant compositions, method of producing the same, and films and multilayer structures made therefrom. The polyolefin composition suitable for sealant applications according to the present invention comprises: an ethylene/α-olefin interpolymer composition having a Comonomer Distribution Constant (CDC) in the range of from 40 to 110, vinyl unsaturation of less than 0.1 vinyls per one thousand carbon atoms present in the backbone of the ethylene-based polymer composition; a zero shear viscosity ratio (ZSVR) in the range of from 1.01 to 2.0; a density in the range of from 0.908 to 0.922 g/cm | 09-17-2015 |
Douglas S. Ginger, Freeport, TX US
Patent application number | Description | Published |
---|---|---|
20150344681 | A POLYOLEFIN COMPOSITION - The instant invention provides a polyolefin composition suitable for injection molding applications, and method of making such injection molded articles. The polyolefin composition suitable for injection molding applications comprises: an ethylene/α-olefin interpolymer composition comprising: (a) from 25 to 50 percent by weight of a first ethylene/α-olefin copolymer fraction having a density in the range of from 0.924 to 0.937 g/cm | 12-03-2015 |
Holt Ginger, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20140140594 | METHODS AND SYSTEMS FOR THREE-DIMENSIONAL REAL-TIME INTRAOPERATIVE SURGICAL MARGIN EVALUATION OF TUMOR TISSUES - In one aspect, the present invention relates to a system evaluating a surgical margin of tumor tissues of a living subject. In one embodiment, the system includes a light source configured to emit a source light; at least one optical probe; a scanner; a spectrometer; and a controller coupled with the scanner and the spectrometer for operably controlling the scanner and the spectrometer. In operation, a working end of the optical probe is positioned proximate to a surface of a specimen of the tumor tissues. A source channel of the optical probe deliver the source light emitted by the light source from the working end to the surface of the specimen, and a plurality of collection channels collect from the working end diffused/reflected light generated from interaction of the source light with the specimen. The spectrometer receives the collected diffused/reflected light to evaluate a margin status of the specimen. | 05-22-2014 |
Rebecca Susan Ginger, Sharnbrook GB
Patent application number | Description | Published |
---|---|---|
20090181115 | Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation - The invention provides a method of identifying compounds that either increase or decrease skin and/or hair pigmentation, the method comprising determining the ability of a test compound to modulate NCKX-mediated calcium ion movement across a membrane (e.g. NCKX5). The method may comprise the steps of exposing a membrane comprising a NCKX molecule or variant, fusion or derivative thereof to a test compound and measuring either directly or indirectly the calcium ion concentration on one or both sides of the membrane. The invention also relates to kits, nucleic acid molecules, polypeptides and cells useful in the method of the invention. | 07-16-2009 |
20140030201 | A SKIN LIGHTENING COMPOSITION - This invention relates to a composition comprising a synergistic combination of ketoconazole and sulforaphane for use in skin lightening. This invention is based on the fact that a combination of ketoconazole and sulforaphane has been found to synergistically inhibit pigment production in B16 monolayer cultures. Thus the composition, when applied topically or imbibed over an appropriate length of time in-vivo, would be expected to cause skin lightening, or to reduce blemishes and/or hyperpigmented spots and/or solar lentigines leading to an improvement in skin tone and evenness. | 01-30-2014 |
Rebecca Susan Ginger, Wirral GB
Patent application number | Description | Published |
---|---|---|
20110268673 | Skin Treatment - The present invention provides a method for determining the predisposition of an individual to a skin condition comprising identifying the profilaggrin alleles present in the genome of an ex vivo sample taken from the individual. Skin conditions include the ability of an individual to produce Natural Moisturising Factors (NMF), dry skin and/or predisposition to detergent-induced erythema. Typically profilaggrin alleles are identified by determining the number of encoded filaggrin repeats. Methods of the invention are particularly useful for grouping individuals for the purposes of participation in clinical trials or for matching an individual to a cosmetic preparation. | 11-03-2011 |